Keynote 224 Results Info. The abstract ‘ pembrolizumab (pembro) monotherapy for previously untreated advanced hepatocellular carcinoma (hcc): Patients were required to have.
We aimed to assess the efficacy and safety of. The abstract ‘ pembrolizumab (pembro) monotherapy for previously untreated advanced hepatocellular carcinoma (hcc):
